STAMPANONI BASSI, MARIO ALBERTO
 Distribuzione geografica
Continente #
EU - Europa 288
AS - Asia 280
NA - Nord America 262
SA - Sud America 1
Totale 831
Nazione #
US - Stati Uniti d'America 247
SG - Singapore 172
DE - Germania 154
HK - Hong Kong 103
IT - Italia 78
CA - Canada 13
EE - Estonia 13
FI - Finlandia 10
GB - Regno Unito 10
RU - Federazione Russa 8
BE - Belgio 5
NL - Olanda 4
AT - Austria 2
BD - Bangladesh 2
ES - Italia 2
MX - Messico 2
BR - Brasile 1
CH - Svizzera 1
IN - India 1
IR - Iran 1
LT - Lituania 1
TR - Turchia 1
Totale 831
Città #
Hong Kong 103
Falkenstein 85
Singapore 84
Frankfurt am Main 59
West Jordan 50
Chicago 44
Rome 44
Boardman 30
Helsinki 10
Toronto 9
Ashburn 8
Los Angeles 8
Moscow 8
Naples 6
Brussels 5
Buffalo 5
Charlotte 5
San Francisco 5
Bologna 4
London 4
Sant'Elpidio a Mare 4
The Dalles 4
Arosio 3
Ettlingen 3
Galbiate 3
New York 3
Ottawa 3
Diano d'Alba 2
Mexico City 2
Turin 2
Zona Industriale 2
Amsterdam 1
Atlanta 1
Boston 1
Chennai 1
Grellingen 1
Montreal 1
Santa Clara 1
Seattle 1
Secaucus 1
São Paulo 1
Totale 617
Nome #
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients 30
Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity 29
Inflammation and Corticospinal Functioning in Multiple Sclerosis: A TMS Perspective 28
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis 26
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis 26
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis 25
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis 25
Interaction between miR-142-3p and BDNF Val/Met Polymorphism Regulates Multiple Sclerosis Severity. 25
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis 25
IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis 24
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis. 24
Exploiting the multifaceted effects of cannabinoids on mood to boost their therapeutic use against anxiety and depression 24
Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients. 24
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity 24
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis 23
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 23
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 23
Case Report: Overlap Between Long COVID and Functional Neurological Disorders 23
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis 22
Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons 22
A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment 22
Obesity worsens central inflammation and disability in multiple sclerosis 22
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 21
Interleukin-1β Alters Hebbian Synaptic Plasticity in Multiple Sclerosis 21
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis. 21
Practice-dependent motor cortex plasticity is reduced in non-disabled multiple sclerosis patients 19
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis 19
Preventive exercise and physical rehabilitation promote long-term potentiation-like plasticity expression in patients with multiple sclerosis 18
Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression 18
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 18
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 18
Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis 18
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 18
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 18
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis 17
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 17
Subclinical dysphagia in task-specific mouth tremor triggered by drinking 16
Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions 16
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 16
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 16
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 15
Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation 14
Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination 13
Totale 906
Categoria #
all - tutte 7.932
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.932


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024164 0 0 0 0 0 0 37 0 0 101 15 11
2024/2025742 28 43 7 45 69 42 164 156 41 28 110 9
Totale 906